Anaphylaxis Treatment Size Share and Forecast 2023

The global anaphylaxis treatment size was valued at USD 3,104.4 million in 2022 and is poised to grow at a significant CAGR of 8.9% during the forecast period 2023-29. The primary drivers of the expansion of the global anaphylaxis treatment market include the increasing incidence of allergies and anaphylaxis. In addition, increasing number of geriatric patients and increasing research and development activities is expected to boost the growth of anaphylaxis market.

View the detailed report description here https://www.precisionbusinessinsights.com/market-reports/global-anaphylaxis-treatment-market

The anaphylaxis treatment market is segmented based on drug class, route of administration, application, distribution channel, and geography.

Based on the drug class, the market is segmented into the following:
• Epinephrine
• Steroids
• Antihistamines
• Beta-antagonists
• Others

Based on the route of administration, the market is segmented into the following:
• Oral
• Parenteral
• Others

Based on the application, the market is segmented into the following:
• Food Allergy
• Pollen Allergy
• Dust Mites Allergy
• Others

Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Based on the application, the global Anaphylaxis Treatment market is segmented into food allergy, pollen allergy, dust mite's allergy, others. The food allergy segment is expected to account for a larger revenue share and highest CAGR in the global anaphylaxis treatment market. The increasing incidence of food allergy in children due to the consumption of junk food is expected to drive the market growth in this segment. For instance, according to reports the prevalence of food allergies in children under 18 years has risen by 50% in the last two decades in the US. These food allergies are caused due to the changing lifestyles and adoption of modern food habits.

North America Anaphylaxis Treatment Market
The North America anaphylaxis treatment market is expected to increase over the forecast period due to the increasing incidence of allergic cases and raising awareness about the anaphylaxis treatment. In addition, changing lifestyles, early diagnosis of specific allergies, and availability of anaphylaxis treatment in this region is expected to drive the growth of anaphylaxis treatment in this region.

Furthermore, increasing number of product launches by the market players and increasing investments in research and development of innovative treatment in this region is expected to further propel the growth of anaphylaxis market in this region over the forecast period.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.

The global Anaphylaxis Treatment market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

For instance, In 2019, Sandoz Inc. launched their product SYMJEPI in the US. a 0.3mg epinephrine injection for the treatment of severe allergic reactions.

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=986583

Key players profiles in the Anaphylaxis Treatment Market report are Pfizer Inc., Mylan N.V, GlaxoSmithKline Plc, Amneal Pharmaceuticals, Merck & Co Inc, Teva Pharmaceutical Industries ltd., Adamis Pharmaceutical Corporation, Abbott Laboratories, Sandoz Inc., Aquestive Therapeutics Inc., Amphastar Pharmaceuticals Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.